[
    [
        {
            "time": "2020-12-31",
            "original_text": "7家企业公布年报：3成净利涨幅超100%，最高达600%，仅4家药企同比下降 盈利能力下降",
            "features": {
                "keywords": [
                    "年报",
                    "净利涨幅",
                    "药企",
                    "盈利能力"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "7家企业公布年报：3成净利涨幅超100%，最高达600%，仅4家药企同比下降 盈利能力下降",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-15",
            "original_text": "沃森生物去年净利大增6倍 今年寻求发行H股在港上市",
            "features": {
                "keywords": [
                    "沃森生物",
                    "净利大增",
                    "H股",
                    "港上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物去年净利大增6倍 今年寻求发行H股在港上市",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-10",
            "original_text": "沃森生物(300142.SZ)2020年度净利润升606.6%至10.03亿元 拟10派0.5元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "净利润",
                    "分红"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)2020年度净利润升606.6%至10.03亿元 拟10派0.5元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "沃森生物(300142.SZ)：拟终止并注销珠海横琴沃森投资基金 并购重组异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "终止",
                    "注销",
                    "并购重组"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：拟终止并注销珠海横琴沃森投资基金 并购重组异常",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "沃森生物(300142.SZ)：拟调整“玉溪沃森疫苗产业园三期工程项目”达到预定可使用状态时间",
            "features": {
                "keywords": [
                    "沃森生物",
                    "调整",
                    "疫苗产业园",
                    "项目进度"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物(300142.SZ)：拟调整“玉溪沃森疫苗产业园三期工程项目”达到预定可使用状态时间",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "沃森生物2020营收净利双增 开启国际化新征程",
            "features": {
                "keywords": [
                    "沃森生物",
                    "营收净利双增",
                    "国际化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物2020营收净利双增 开启国际化新征程",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-20",
            "original_text": "沃森生物年报：自主疫苗发力净利增逾六倍 将持续推进全面国际化战略",
            "features": {
                "keywords": [
                    "沃森生物",
                    "自主疫苗",
                    "净利增",
                    "国际化战略"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物年报：自主疫苗发力净利增逾六倍 将持续推进全面国际化战略",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-10",
            "original_text": "沃森生物：13价肺炎疫苗贡献超5成营收，销售费用11亿占营收比近4成",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价肺炎疫苗",
                    "销售费用"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：13价肺炎疫苗贡献超5成营收，销售费用11亿占营收比近4成",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "每日“药”闻|蓝帆医疗商誉减值17.6亿；多家药企公布业绩，先声药业利润下滑34%",
            "features": {
                "keywords": [
                    "药企",
                    "商誉减值",
                    "利润下滑"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "每日“药”闻|蓝帆医疗商誉减值17.6亿；多家药企公布业绩，先声药业利润下滑34%",
                "Correlation": 4,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-20",
            "original_text": "沃森生物2020年营收净利大幅增长 今年将稳步推进港股上市进程",
            "features": {
                "keywords": [
                    "沃森生物",
                    "营收净利增长",
                    "港股上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物2020年营收净利大幅增长 今年将稳步推进港股上市进程",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]